However, monocytes from patients with LR-MDS had significantly higher levels of CD56 (p = 0.006), and lower levels of CD11c (p = 0.004), CD16 (p = 0.005) and HLA-DR (p = 0.042), and showed a tendency for a lower CD11b expression (p = 0.089), as compared to controls. The gene discussed is NCAM1; the disease is myelodysplastic syndrome.